Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (161-170 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Antimicrobial Chemotherapy|March 4, 2026
Infant HIV transmission despite maternal viral suppression: a case of post-weaning seroconversionShadia Nakalema, Diana Namuddu, Isabella Kyohairwe, et al.
Bioanalysis|November 20, 2018
Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milkJoshua Gini, Sujan Dilly Penchala, Alieu Amara, et al.
AIDS (London, England)|April 18, 2003
Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoringMarta Boffito, David J Back, Patrick G Hoggard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2012
Steady-state pharmacokinetics of lopinavir plus ritonavir when administered under different meal conditions in HIV-infected Ugandan adultsMohammed Lamorde, Pauline Byakika-Kibwika, Marta Boffito, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2014
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapyBorja Mora-Peris, Victoria Watson, Jaime H Vera, et al.
Plos One|June 11, 2014
HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyChristine M Kelly, Joep J van Oosterhout, Chisomo Ngwalo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2023
Prevalence of Potentially Clinically Significant Drug-Drug Interactions With Antiretrovirals Against HIV Over Three Decades: A Systematic Review of the LiteratureDaryl Hodge, Eva Maria Hodel, Elen Hughes, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteersAkil Jackson, Andrew Hill, Rebekah Puls, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2008
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavirMarco Siccardi, Antonio D'Avolio, Lorena Baietto, et al.
Infectious Diseases and Therapy|January 10, 2016
Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case ReportsJulie Fox, Michael Brady, Hannah Alexander, et al.
Pageof 29

Showing results (161-170 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Antimicrobial Chemotherapy|March 4, 2026
Infant HIV transmission despite maternal viral suppression: a case of post-weaning seroconversionShadia Nakalema, Diana Namuddu, Isabella Kyohairwe, et al.
Bioanalysis|November 20, 2018
Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milkJoshua Gini, Sujan Dilly Penchala, Alieu Amara, et al.
AIDS (London, England)|April 18, 2003
Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoringMarta Boffito, David J Back, Patrick G Hoggard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 7, 2012
Steady-state pharmacokinetics of lopinavir plus ritonavir when administered under different meal conditions in HIV-infected Ugandan adultsMohammed Lamorde, Pauline Byakika-Kibwika, Marta Boffito, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2014
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapyBorja Mora-Peris, Victoria Watson, Jaime H Vera, et al.
Plos One|June 11, 2014
HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyChristine M Kelly, Joep J van Oosterhout, Chisomo Ngwalo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2023
Prevalence of Potentially Clinically Significant Drug-Drug Interactions With Antiretrovirals Against HIV Over Three Decades: A Systematic Review of the LiteratureDaryl Hodge, Eva Maria Hodel, Elen Hughes, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2010
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteersAkil Jackson, Andrew Hill, Rebekah Puls, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2008
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavirMarco Siccardi, Antonio D'Avolio, Lorena Baietto, et al.
Infectious Diseases and Therapy|January 10, 2016
Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case ReportsJulie Fox, Michael Brady, Hannah Alexander, et al.
Pageof 29